TR199600583A2 - Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi. - Google Patents

Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.

Info

Publication number
TR199600583A2
TR199600583A2 TR96/00583A TR9600583A TR199600583A2 TR 199600583 A2 TR199600583 A2 TR 199600583A2 TR 96/00583 A TR96/00583 A TR 96/00583A TR 9600583 A TR9600583 A TR 9600583A TR 199600583 A2 TR199600583 A2 TR 199600583A2
Authority
TR
Turkey
Prior art keywords
tolerability
increasing
amino acids
pharmaceutical activity
pharmaceutical
Prior art date
Application number
TR96/00583A
Other languages
English (en)
Inventor
Michael Matzke
Hans-Christian Militzer
Joachim Mittendorf
Franz Kunisch
Axel Schmidt
Wolfgang Schoenfeld
Karl Ziegelbauer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of TR199600583A2 publication Critical patent/TR199600583A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
TR96/00583A 1995-07-19 1996-07-16 Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi. TR199600583A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526274A DE19526274A1 (de) 1995-07-19 1995-07-19 Verbesserung der Verträglichkeit von pharmazeutisch wirksamen beta-Aminosäuren

Publications (1)

Publication Number Publication Date
TR199600583A2 true TR199600583A2 (tr) 1997-02-21

Family

ID=7767189

Family Applications (1)

Application Number Title Priority Date Filing Date
TR96/00583A TR199600583A2 (tr) 1995-07-19 1996-07-16 Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.

Country Status (45)

Country Link
US (1) US5935988A (tr)
EP (2) EP1043332B1 (tr)
JP (2) JP3891503B2 (tr)
KR (1) KR100433968B1 (tr)
CN (1) CN1115145C (tr)
AR (1) AR003465A1 (tr)
AT (2) ATE344274T1 (tr)
AU (1) AU713555B2 (tr)
BG (1) BG62134B1 (tr)
BR (1) BR9603124A (tr)
CA (1) CA2181308A1 (tr)
CO (1) CO4700525A1 (tr)
CU (1) CU22820A3 (tr)
CZ (2) CZ287896B6 (tr)
DE (3) DE19526274A1 (tr)
DK (2) DK0754678T3 (tr)
DZ (1) DZ2073A1 (tr)
EE (1) EE03803B1 (tr)
ES (2) ES2275460T3 (tr)
GR (1) GR3035601T3 (tr)
HK (1) HK1005131A1 (tr)
HR (1) HRP960303B1 (tr)
HU (1) HUP9601977A3 (tr)
IL (1) IL118869A (tr)
MA (1) MA23940A1 (tr)
MX (1) MX9602836A (tr)
NO (1) NO315926B1 (tr)
NZ (1) NZ299008A (tr)
PE (1) PE9398A1 (tr)
PL (1) PL184861B1 (tr)
PT (2) PT754678E (tr)
RO (1) RO118656B1 (tr)
RS (1) RS49520B (tr)
RU (1) RU2181123C2 (tr)
SA (1) SA96170491B1 (tr)
SG (1) SG47158A1 (tr)
SI (2) SI1043332T1 (tr)
SK (2) SK281850B6 (tr)
SV (1) SV1996000062A (tr)
TN (1) TNSN96100A1 (tr)
TR (1) TR199600583A2 (tr)
TW (1) TW496737B (tr)
UA (1) UA46725C2 (tr)
YU (1) YU20050685A (tr)
ZA (1) ZA966111B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine
KR20010073441A (ko) * 2000-01-14 2001-08-01 최인도 패류종묘 착상판의 제조방법
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
KR101170840B1 (ko) * 2003-05-29 2012-08-03 샤이어 엘엘씨 남용 방지성 암페타민 화합물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716278D0 (en) * 1987-07-10 1987-08-19 Fujisawa Pharmaceutical Co Antimicrobial agent
JPH02174753A (ja) * 1988-08-25 1990-07-06 Fujisawa Pharmaceut Co Ltd シス―２―アミノシクロペンタンカルボン酸誘導体およびその製法ならびに抗菌剤
US5631291A (en) * 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
DE4302155A1 (de) * 1993-01-27 1994-07-28 Bayer Ag Verwendung von Cyclopentan- und -penten-beta-Aminosäuren
GB9216441D0 (en) * 1992-08-03 1992-09-16 Ici Plc Fungicidal process
WO1995007022A1 (en) * 1993-09-07 1995-03-16 Zeneca Limited Fungicides
DE19548825C2 (de) * 1995-12-27 1999-03-25 Rolf Dr Hermann Neue, substituierte Cyclopentylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19604225A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Stoffzusammensetzungen aus alpha-Aminosäuren und Cyclohexen-beta-aminosäuren

Also Published As

Publication number Publication date
EP1043332A1 (de) 2000-10-11
SA96170491B1 (ar) 2006-09-20
MX9602836A (es) 1997-01-31
DE59611398D1 (de) 2006-12-14
CU22820A3 (es) 2003-01-29
SI1043332T1 (sl) 2007-04-30
ZA966111B (en) 1997-02-03
SK284733B6 (sk) 2005-10-06
NO963000D0 (no) 1996-07-18
AU5948896A (en) 1997-01-23
NO963000L (no) 1997-01-20
SV1996000062A (es) 1997-06-26
AU713555B2 (en) 1999-12-02
PT754678E (pt) 2001-04-30
DZ2073A1 (fr) 2002-07-22
YU41796A (sh) 1999-06-15
ES2154761T3 (es) 2001-04-16
EP0754678B1 (de) 2001-01-03
DK0754678T3 (da) 2001-02-05
PL184861B1 (pl) 2003-01-31
HRP960303B1 (en) 2001-08-31
CZ288204B6 (en) 2001-05-16
TW496737B (en) 2002-08-01
BR9603124A (pt) 1998-04-22
CO4700525A1 (es) 1998-12-29
SK94796A3 (en) 1997-02-05
KR970006312A (ko) 1997-02-19
EP0754678A3 (de) 1997-12-17
PE9398A1 (es) 1998-04-15
SK281850B6 (sk) 2001-08-06
TNSN96100A1 (fr) 2005-03-15
ES2275460T3 (es) 2007-06-16
HK1005131A1 (en) 1998-12-24
SG47158A1 (en) 1998-03-20
EE9600109A (et) 1997-02-17
ATE344274T1 (de) 2006-11-15
KR100433968B1 (ko) 2004-08-30
CN1115145C (zh) 2003-07-23
NO315926B1 (no) 2003-11-17
NZ299008A (en) 1998-05-27
SI0754678T1 (en) 2001-04-30
BG62134B1 (bg) 1999-03-31
YU20050685A (sh) 2006-08-17
JP2007056026A (ja) 2007-03-08
HU9601977D0 (en) 1996-09-30
CA2181308A1 (en) 1997-01-20
RO118656B1 (ro) 2003-08-29
EE03803B1 (et) 2002-08-15
CZ287896B6 (cs) 2001-03-14
DE19526274A1 (de) 1997-01-23
DK1043332T3 (da) 2007-03-12
UA46725C2 (uk) 2002-06-17
RU2181123C2 (ru) 2002-04-10
IL118869A0 (en) 1996-10-31
PT1043332E (pt) 2007-01-31
RS49520B (sr) 2006-10-27
EP0754678A2 (de) 1997-01-22
PL315330A1 (en) 1997-01-20
EP1043332B1 (de) 2006-11-02
IL118869A (en) 2002-03-10
JPH09202761A (ja) 1997-08-05
DE59606266D1 (de) 2001-02-08
CN1143496A (zh) 1997-02-26
HRP960303A2 (en) 1998-02-28
HUP9601977A2 (en) 1997-05-28
AR003465A1 (es) 1998-08-05
CZ214396A3 (en) 1997-02-12
ATE198469T1 (de) 2001-01-15
JP3891503B2 (ja) 2007-03-14
MA23940A1 (fr) 1997-04-01
US5935988A (en) 1999-08-10
BG100716A (bg) 1997-04-30
HUP9601977A3 (en) 1998-04-28
GR3035601T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
NL300190I1 (nl) Farmaceutische formuleringen met darifenacine.
HK1030768A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents.
NO954146D0 (no) Belagte farmasöytiske preparater
BR9611367A (pt) Formulação farmacêutic liofilizada estável
DE69513671T2 (de) Arzneimittel
DE69629755D1 (de) Irbesartanhaltiges Arzneimittel
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
NO306342B1 (no) Syntetiske eksitatoriske aminosyrer, farmasöytisk formulering inneholdende slike aminosyrer samt mellomprodukt
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69737936D1 (de) Arzneimittel
BR9304747A (pt) Injetor de medicamentos
BR9610396A (pt) Formulação farmacêutica
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
TR199600583A2 (tr) Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
FI964619A (fi) Epilepsialääkkeiden iholle annostelu
FR2716375B3 (fr) Injecteur médical.
EE9600208A (et) Uued immuunomodulatoorse toimega peptiidid
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
FI951155A0 (fi) Farmaseuttinen valmiste
ITMI942358A0 (it) Peptidi ad attivita' antiinfiammatoria
DE59610423D1 (de) Partikulare arzneiform
DE69508700D1 (de) Aminosäurederivat mit Anti-CCK-Aktivität